年龄愤怒路径:心血管疾病和氧化应激
Neeraj Sharma1, Pavan Kumar2, Karuna Shanker Shukla3
1Department of Pharmacy, Bhagwant University, Ajmer, India.
Drug research
|June 12, 2023
概括
先进的甘化终产物 (AGEs) 和它们的受体 (RAGE) 驱动心血管疾病. 用诸如chyrsin这样的化合物准 AGE-RAGE 轴显示出治疗糖尿病并发症和炎症的前景.
科学领域:
- 生物化学 生物化学
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 先进的甘化终产物 (AGEs) 和它们的受体 (RAGE) 是心血管疾病的关键驱动因素,特别是在糖尿病中.
- AGE-RAGE轴调解氧化应激和炎症,有助于心脏代谢病理.
- 现有的AGE-RAGE抑制剂在动物模型中表现有前途,但临床疗效需要进一步研究.
研究的目的:
- 探索针对心血管疾病的 AGE-RAGE轴的治疗策略.
- 为了研究天然化合物,如chyrsin的抗炎和抗氧化特性.
- 评估 AGE-RAGE 相互作用在氧化应激和炎症相关疾病中的作用.
主要方法:
- 关于AGE-RAGE抑制剂和PPAR-agonists的现有文献的审查.
- 分析涉及其PPAR-agonist,抗氧化剂和抗炎作用的chyrsin的研究.
- 对动物模型的检查表明,AGE-RAGE轴参与了化和视网膜病变等疾病,包括氧化应激标志物 (SOD2,ROS,GSH).
主要成果:
- PPAR-agonists在抑制心脏代谢疾病的AGE-RAGE轴方面表现出有效性.
- 氨酸表现出PPAR-agonist活性,并具有抗氧化和抗炎性质.
- 在实验模型中,抑制AGE-RAGE信号减少了炎症和氧化应激标志物.
结论:
- 针对 AGE-RAGE 轴是一个有前途的治疗策略,用于心血管和糖尿病并发症.
- 像基尔辛这样的天然化合物需要进一步研究它们在治疗AGE-RAGE介导疾病方面的潜力.
- 了解 AGE-RAGE,炎症和氧化应激之间的相互作用对于开发有效的治疗方法至关重要.
相关概念视频
01:26Aging
89
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
89
01:30Coronary Artery Disease I: Introduction
33
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
33
01:26Coronary Artery Disease II: Pathophysiology
15
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
15
01:19The Effect of Aging on Tissues
2.2K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.2K
01:30Atherosclerosis I: Introduction
13
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
13
01:17Pathophysiology of Heart Failure
1.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K